Sean Bohen

Sean Bohen is a declared insider of Olema Pharmaceuticals, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 1 September 2021 to 26 December 2025.

Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 4 option exercises.

The record was last updated on 30 December 2025 with a transaction in Olema Pharmaceuticals, Inc. The last insider purchase was made public on 23 September 2022, 1,486 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.